New Technologies to Improve Clinical Trials
The Association Between Intravenous Haloperidol and Prolonged QT Interval
The 35% CO 2 Hyperreactivity and Clinical Symptomatology in Patients With Panic Disorder After 1 Week of Treatment With Citalopram: An Open Study
Pharmacokinetics and Clinical Effects of Sublingual Triazolam in Pediatric Dental Patients
Reinforcing and Subject-Rated Effects of Methylphenidate and d-Amphetamine in Non–Drug-Abusing Humans
Targeted Use of Naltrexone Without Prior Detoxification in the Treatment of Alcohol Dependence: A Factorial Double-Blind, Placebo-Controlled Trial
Antidepressants and Ejaculation: A Double-Blind, Randomized, Placebo-Controlled, Fixed-Dose Study With Paroxetine, Sertraline, and Nefazodone
The Relative Efficacy of Fluoxetine and Manual-Based Self-Help in the Treatment of Outpatients With Bulimia Nervosa
MEETING ANNOUNCEMENTS
Therapeutic Drug Monitoring of Clozapine in Relapse Prevention: A Five-Year Prospective Study
Psychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Bupropion Sustained-Release for the Treatment of Dysthymic Disorder: An Open-Label Study
Concentrations of the Enantiomers of Fluoxetine and Norfluoxetine After Multiple Doses of Fluoxetine in Cytochrome P4502D6 Poor and Extensive Metabolizers
Double-Blind, Controlled, Crossover Trial of Inositol Versus Fluvoxamine for the Treatment of Panic Disorder
A Pilot Study of Topiramate as Monotherapy in the Treatment of Acute Mania
Improvement of Hallucinogen-Induced Persistent Perception Disorder by Treatment With a Combination of Fluoxetine and Olanzapine: Case Report
New Hope for Hallucinogen-Induced Persistent Perceptual Disorder?
Comments on “Serotonin Syndrome During Treatment With Paroxetine and Risperidone”
Comments on “Hypotension Associated With Intravenous Haloperidol and Imipenem”
Tiagabine, a Specific γ-Aminobutyric Acid Transporter-1 Inhibitor, in the Treatment of Psychosis
Exogenous Melatonin, Jet Lag, and Psychosis: Preliminary Case Results
Hyperglycemia in Patients With Schizophrenia Who Are Treated With Olanzapine
Antiaggressive Action of Atypical Antipsychotics in Patients With Schizophrenia
Treating Tardive Dyskinesia With Ondansetron